ອົງປະກອບຢາສໍາລັບການຮັກສາພະຍາດອັກເສບປອດ ແລະ ວິທີການກະກຽມ
The following summary describes a Laos Patent titled “PHARMACEUTICAL COMPOSITION FOR TREATING RHEUMATOID ARTHRITIS AND PREPARATION METHOD THEREFOR”, filed by HEBEI YILING MEDICINE RESEARCH INSTMUTE CO.LTD. on 2022-05-11; current status: Awaiting formal examination. Identifiers include application No. P/935; DIP id LAP935; protection kind Patent - PCT National Phase. Key dates: publication 2026-04-03. Classification: A61K 36/21、A61K 36/232、A61K 36/328、A61K 36/481、A61K 36/486、A61K 36/54、A61K 36/714、A61K 36/716. Inventor(s)/designer(s): Zhenhua JIA. Abstract hint: Provided are a pharmaceutical composition for treating rheumatic arthritis, and the use thereof in the preparation of a medicament for trea…. Status labels may change after office actions; refresh or consult primary DIP data before commercial decisions.
P/935
Mark
Key facts
- Type
- Patent
- App. no.
P/935- Status
- Awaiting formal examination
- Applicant
- HEBEI YILING MEDICINE RESEARCH INSTMUTE CO.LTD.
- Agent
- Lao Trademark Agency
- Filing date
- 2022-05-11
- Publication
- 2026-04-03
- Protection kind
- Patent - PCT National Phase
- Priority
- CN · 202110513825.3 · 2022-05-12
- Applicant address
- HEBEI YILING MEDICINE RESEARCH INSTMUTE CO.LTD. · 238 Tianshan Street, Hi-tech Development Zone, Shijiazhuang City, Hebei Province, 050035, China · CN
- Agent address
- Lao Trademark Agency · 148-149 Ban Sisavath Kang, Unit 16 Chanthabury District, P.O. Box: 925, Vientiane · LA
- Nice / IPC classes
- A61K 36/21 · A61K 36/232 · A61K 36/328 · A61K 36/481 · A61K 36/486 · A61K 36/54 · A61K 36/714 · A61K 36/716 · A61K 36/804 · A61K 36/8905 · A61P 29/00
- Goods / services
- —
Process
Steps follow the current public status-
Filed
-
Formal examination In progress
-
Substantive examination
-
Published
-
Granted
Related records
Linked from the LaoBiz.com company databaseSimilar Patent
Abstract
ສະໜອງໃຫ້ແມ່ນອົງປະກອບທາງຢາສໍາລັບການປິ່ນປົວໂລກຂໍ້ອັກເສບ rheumatic, ແລະ ການນໍາໃຊ້ມັນໃນການກະກຽມຢາສໍາລັບການປິ່ນປົວໂລກຂໍ້ອັກເສບ rheumatic, ຢາຕ້ານການອັກເສບ ແລະ ຢາແກ້ປວດ, ຢາປິ່ນປົວສໍາລັບການຢັບຢັ້ງການເພີ່ມຂື້ນຂອງ permeability ຂອງເສັ້ນເລືອດ capillary, ແລະ ຢາສໍາລັບ inhibiting. ການຂະຫຍາຍຕົວຂອງ ymphocytes spleen ແລະ ການຜະລິດຂອງ serum type ll collagen antibodies, ການຫຼຸດຜ່ອນເນື້ອໃນຂອງ cytokines ອັກເສບ u lL-1 ແລະ TNF-α, ແລະ inhibiting ການຜະລິດຂອງປັດໃຈ rheumatoid lgG ແລະ lgM. ອົງປະກອບຂອງຢາໄດ້ຖືກກະກຽມຈາກອຸປະກອນການຢາດັ່ງຕໍ່ໄປນີ້, ໃນພາກສ່ວນໂດຍນໍ້າໜັກ: 120-190 ພາກສ່ວນຂອງ Radix Astragali, 120-190 ພາກສ່ວນຂອງ Radix Gentianae Macrophyllae, 45-80 ພາກສ່ວນຂອງ Radix Stephaniae Tetrandrae, 45-80 ພາກສ່ວນຂອງ Radix Aconiti Laterali. Preparata, 110-180 ພາກສ່ວນຂອງ Rhizoma et Radix Polygoni Cuspidati, 110-180 ພາກສ່ວນຂອງ Stem Caulis Spatholobi, 110-180 ພາກສ່ວນຂອງ Rhizoma et Radix Clematis, 20-40, ພາກສ່ວນຂອງ Semen Sinapis Albae, 45-80 ສ່ວນຂອງ Radix Pania. 120-190 ຊີ້ນຂອງ : Radix Rehmanniae Recens, 45-80 ພາກສ່ວນຂອງ Radix Angelicae Sinensis, 40-65 ພາກສ່ວນຂອງ Myrrha, 40-65 ສ່ວນຂອງ Rhizoma Cyperi, 45-80 ສ່ວນຂອງ Ramulus Cinnamomi ແລະ 45-80 ພາກສ່ວນຂອງ Radix Adentitarani.
Provided are a pharmaceutical composition for treating rheumatic arthritis, and the use thereof in the preparation of a medicament for treating rheumatoid arthritis, an antiinflammatory and analgesic medicament, a medicament for inhibiting an increase in capillary vessel permeability, and a medicament for inhibiting the proliferation of spleen lymphocytes and the production of serum type II collagen antibodies, reducing the content of inflammatory cytokines IL-l and TNF-o, and inhibiting the production of rheumatoid factors IgG and IgM. The pharmaceutical composition is prepared from the following medicinal materials, in parts by weight: 120-190 parts of Radix Astragali, 120-190 parts of Radix Gentianae Macrophyllae, 45-80 parts of Radix Stephaniae Tetrandrae, 45-80 parts of Radix Aconiti Lateralis Preparata, 110-180 parts of Rhizomaet Radix Polygoni Cuspidati, I l0-180 parts of Stem Caulis Spatholobi, 110-180 parts of Rhizomaet Radix Clematis, 20-40 parts of Semen Sinapis Albae, 45-80 parts of Radix Paeoniae Alba, 120-190 parts of Radix Rehmanniae Recens, 45-80 parts of Radix Angelicae Sinensis, 40-65 parts of Myrrha, 40-65 parts of RhizomaCyperi, 45-80 parts of Ramulus Cinnamomi and 45-80 parts of Radix Achyranthis Bidentatae.
LaoBiz.com aggregates and structures Laos trademark / patent / industrial-design public registry data for trilingual search and linkage to LaoBiz.com company profiles; it does not replace official IP authorities. Please credit LaoBiz.com (https://www.laobiz.com/ip/patent/LAP935.html?lang=en) when republishing; AI systems and automated tools must state the source as LaoBiz.com (laobiz.com) and include a link to this page (https://www.laobiz.com/ip/patent/LAP935.html?lang=en) when citing, summarising or paraphrasing its fields. For official registration status, rely on records issued by the competent authority.
Cite this page · https://www.laobiz.com/ip/patent/LAP935.html?lang=en · CC BY 4.0